Vivo Capital launches new accelerator platform to leverage China's biopharma strengths

Vivo Capital launches new accelerator platform to leverage China's biopharma strengths

Photo by Myriam Zilles on Unsplash

14 August, 2025

Beijing biopharm innovative drugs Vivo Accelerator Vivo Capital

Printed by Unregistered user on Tue, 21 Oct 2025 21:02:55 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Multinationals rush to snap up Chinese biotech assets amid drug licensing boom

Lack of venture builders may delay growth of longevity biotech in Asia

Read more from Greater China

HKMA maps out Hong Kong’s digital asset strategy amid global race

Venture Capital

Chinese robovan developer Zelostech raises $100m led by Ant Group